Stuttgart - Delayed Quote • EUR
AnaptysBio, Inc. (AN6.SG)
At close: April 26 at 5:47 PM GMT+2
Growth Estimates
| CURRENCY IN USD | AN6.SG | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | -- |
| Next Qtr. | -- | -- | -- | -- |
| Current Year | -- | -- | -- | -- |
| Next Year | -- | -- | -- | -- |
| Next 5 Years (per annum) | -- | -- | -- | -- |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Initiated | Leerink Partners: Outperform | 4/16/2024 |
| Initiated | Wells Fargo: Overweight | 4/11/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 4/1/2024 |
| Upgrade | Wedbush: Neutral to Outperform | 3/12/2024 |
| Initiated | BTIG: Buy | 2/26/2024 |
| Initiated | Stifel: Buy | 2/21/2024 |
Related Tickers
TARA Protara Therapeutics, Inc.
2.9250
-4.10%
XNCR Xencor, Inc.
19.98
+3.90%
MORF Morphic Holding, Inc.
28.07
+0.32%
RVMD Revolution Medicines, Inc.
35.96
+1.78%
GLPG Galapagos NV
28.76
+0.45%
ANAB AnaptysBio, Inc.
21.00
+11.29%
PRTA Prothena Corporation plc
20.87
+1.51%
RLFTF Relief Therapeutics Holding SA
1.4500
0.00%
ARVN Arvinas, Inc.
32.37
+2.44%
QNRX Quoin Pharmaceuticals, Ltd.
0.6375
+1.21%